# Avita Medical Inc. (RCEL) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Technology. Price $11.20, market value $346 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Avita Medical Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 4.6×**. Each dollar of revenue is priced at 4.6×.
- **Free-cash-flow yield: -7.5%** (5-yr avg -15.9%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 81.6%**. Avita Medical Inc. keeps 81.6% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: -46.6%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -67.8%**. The company reported a net loss over the last twelve months.
- **Return on equity: 291.8%**. A 291.8% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on invested capital: -172.9%**. Return on all capital, debt included, is -172.9%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -76.4%**. Each dollar of assets produces -76.4% of profit.

## Growth
- **Revenue growth (1 yr): 11.5%** (3-yr 27.7%/yr, 5-yr 38.1%/yr). Revenue grew 11.5% over the last year, against 38.1% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 27.2%**. Earnings per share rose 27.2%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Net debt / EBITDA: net cash**. Avita Medical Inc. holds more cash than debt.
- **Altman Z-score: 1.21**. A Z-score of 1.21 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Avita Medical Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (3 analysts). 3 analysts cover Avita Medical Inc.; the consensus is strong_buy, with an average price target of $12.49 (+11% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 161.1%** (YTD 224.6%, 3-mo 167.9%). The shares are up 161.1% over twelve months including dividends.
- **From 52-week high: -1.7%** (247.8% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 79**. An RSI of 79 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 1.64** (volatility 110%). Beta of 1.64 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=RCEL · Page: https://foliofundamentals.com/stocks/rcel

Not investment advice.